THIOGENESIS THERAPEUTICS COR (TTI.CA) Stock Cash Flow

TSX-V:TTI • CA88410L1022

0.48 CAD

+0.02 (+4.35%)

Last: Mar 27, 2026, 07:00 PM

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

Quarterly Statements

Show Percentage Diff	TTM (2025-9-30)	2024 (2024-12-31)	2023 (2023-12-31)	2022 (2022-12-31)	2021 (2021-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income	-6.82M	-3.15M	-5.06M	100.00K	N/A
Change In Working Capital	1.35M	-1.12M	1.30M	N/A	N/A
Other non cash items	807.10K	349.00K	515.70K	N/A	N/A
OPERATING CASH FLOW	-4.66M	-3.92M	-3.25M	100.00K	N/A

CASH FLOWS FROM INVESTING ACTIVITIES
Other Investing Activity	N/A	N/A	0.00	N/A	N/A
INVESTING CASH FLOW	N/A	N/A	0.00	N/A	N/A

CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced	N/A	N/A	0.00	N/A	N/A
Stock Issued/Repurchased	N/A	723.40K	4.12M	N/A	N/A
FINANCING CASH FLOW	N/A	723.40K	4.12M	N/A	N/A

Exchange Rate Effect	-45.80K	-31.30K	7.60K	N/A	N/A
CHANGE IN CASH	-644.80K	-3.23M	880.30K	100.00K	0.00

FREE CASH FLOW
Operating Cash Flow	-4.66M	-3.92M	-3.25M	100.00K	N/A
FREE CASH FLOW	-4.66M	-3.92M	-3.25M	100.00K	N/A

All data in CAD

Charts